DDNews Top 5 Cancer Stories
OCTOBER 2014
 
 
 
 
From our October 2014 issue:
By Ilene Schneider, DDNews Contributing Editor
Seattle Genetics and Genmab create new ADC collaboration, adding to Genmab's preclinical pipeline
 
From our October 2014 issue:
By Lori Lesko, DDNews Contributing Editor
Bristol-Myers Squibb, Celgene deliver one-two punch to beat breast cancer
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
If all milestones are met, the agreement could be worth up to $817 million
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
The organizations will seek to advance compounds from programs at EMD Serono and the ICR
 
From DDNews Daily News:
By Lloyd Dunlap, DDNews Managing Editor
Service center will allow the expansion of new immunotherapy experimental platforms to advance translational medical research and the treatment of cancers
 
 
   
©2014 Old River Publications LLC. All Rights Reserved.
Web site designed and managed by Offenberger & White, Inc..
If you no longer wish to receive DDNEWS mailings, please unsubscribe here.